| Dr Christopher Tudor Baughman-oprica, PHARMD | |
|
830 Chalkstone Ave, 119, Providence, RI 02908-4734 | |
| (401) 273-7100 | |
| Not Available |
| Full Name | Dr Christopher Tudor Baughman-oprica |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacotherapy |
| Location | 830 Chalkstone Ave, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003270547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1200X | Pharmacist - Pharmacotherapy | PCT.0013264 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Tudor Baughman-oprica, PHARMD 830 Chalkstone Ave, 119, Providence, RI 02908-4734 Ph: (401) 273-7100 | Dr Christopher Tudor Baughman-oprica, PHARMD 830 Chalkstone Ave, 119, Providence, RI 02908-4734 Ph: (401) 273-7100 |
News Archive
The American Medical Group Association (AMGA) today presented the 2012 AMGA Acclaim Award to HealthPartners for "Triple Aim 2.0: Designing Culture to Support Better Health, Better Experience at a Lower Cost," an inventive and patient-centered approach to align the Institute of Medicine's Aims to identify and drive performance improvement, innovation, and culture throughout the organization.
Management consultant Hay Group expects that annual premium increases for health coverage will average approximately 9 percent during 2010. This estimate represents the increase in premiums before any changes in plan design, medical management or plan administration.
As the number of coronavirus disease (COVID-19) cases skyrocket to a staggering 18 million, the race to attain vaccine approval is on. More than a hundred candidate vaccines are being developed and tested to prevent infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, many vaccine candidates are undergoing human stage 2 and 3 trials to prove their efficacy and safety.
The Board of Directors of Sinobiomed Inc. is pleased to announce the sale of the Company's wholly-owned BVI subsidiary, Wanxin Bio-Technology Limited and its Chinese subsidiaries, Shanghai Wanxin Bio-Pharmaceutical Co Ltd. and Shanghai Bio-Science Cosmetic Co Ltd.
CENTOGENE AG announces the launch of the world's largest genetic mutation database for rare diseases, CentoMD. CentoMD is a comprehensive and unique repository of genetic variants, including a huge number of unpublished pathogenic variants gathered from patients worldwide.
› Verified 1 days ago
Dr. Adedayo A Olayanju, PHARM D.,RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 711 Broad St, Providence, RI 02907 Phone: 401-331-9550 | |
Dr. Anthonia Kuti, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 533 Elmwood Ave, Providence, RI 02907 Phone: 401-781-7930 | |
James E Fontes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1140 N Main St, Providence, RI 02904 Phone: 401-278-4901 Fax: 401-278-4907 | |
Areum Mo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 114-74 Exchange Street, Providence, RI 02903 Phone: 770-906-2213 | |
Diane Kenameh-nteinmusi Ayuninjam, PHARMD, MPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 180 Corliss St, Providence, RI 02904 Phone: 401-793-4582 | |
Ms. Nancy Lisbeth Tynan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 830 Chalkstone Ave, Providence, RI 02908 Phone: 401-273-7100 Fax: 401-457-3372 |